Literature DB >> 6492296

Cellular changes with graded limb ischemia and reperfusion.

M O Perry, G T Shires, S A Albert.   

Abstract

Following distal arterial and venous cannulations in both hind limbs of 10 dogs, left leg arterial pressure was reduced to less than 50 torr (group I) and 50 to 75 torr (group II). Muscle membrane potential difference (PD) measurements, muscle biopsies, and arterial and venous blood samples were taken at baseline, after 3 hours of ischemia, and following 3 hours of reperfusion. Blood gas tensions and blood and muscle metabolites were measured. Muscle creatine phosphate levels fell during the ischemic period, but the adenosine triphosphate concentration remained normal. The PD fell in both groups during ischemia and declined further after reperfusion (p greater than 0.01). The deterioration in cell membrane function occurred in spite of intracellular energy repletion and persisted after reperfusion. The PD appears to be a more sensitive indicator of ischemia-induced cell dysfunction than levels of blood or intracellular metabolites. The cause of the progressive fall in the membrane potential is uncertain, but it may be due to cytotoxicity produced by oxygen free radicals.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6492296

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

1.  Limb salvage versus traumatic amputation. A decision based on a seven-part predictive index.

Authors:  W L Russell; D M Sailors; T B Whittle; D F Fisher; R P Burns
Journal:  Ann Surg       Date:  1991-05       Impact factor: 12.969

2.  The role of oxygen-derived free radicals and the effect of free radical scavengers on skeletal muscle ischemia/reperfusion injury.

Authors:  A Seyama
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  Early Thrombosuction and Tirofiban Use in Knee and Below-Knee Arterial Thrombosis.

Authors:  Ulas Bildirici; Umut Celikyurt; Sadan Yavuz; Emir Dervis; Qurban Adina; Dilek Ural
Journal:  Med Sci Monit       Date:  2017-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.